Suggestions
Aaron Sato
Biologics R&D Executive Leader | Research Scientist | Antibody Discovery & Engineering | Drug Discovery | Technology Expert
Aaron Sato is a seasoned biologics R&D scientist and executive leader with more than 25 years of experience specializing in the discovery and advancement of innovative first-in-class antibody therapeutics.
Currently holding the position of Chief Scientific Officer at Twist Bioscience, Aaron plays a pivotal role in steering new product development and pipeline initiatives within the biopharma division by harnessing Twist's cutting-edge DNA synthesis technology to produce synthetic libraries, genes, and oligo pools.
As the driving force behind M&A activities and an executive sponsor for new drug discovery and CRO acquisitions such as Abveris, Aaron exhibits a keen eye for strategic growth opportunities and industry partnerships to further the company's objectives.
Beyond his role at Twist Bioscience, Aaron also serves as the CEO of Spin Therapeutics, a virtual biotech company focused on pioneering serine proteinase inhibitors tailored for rare diseases, showcasing his entrepreneurial spirit and commitment to addressing unmet medical needs.
With a profound dedication to leveraging his proficiency in antibody discovery, protein biochemistry, and engineering, Aaron is driven by a passion to enhance patient outcomes and make a significant impact in the healthcare sector.
His illustrious career is underscored by a wealth of accomplishments, including the publication of over 50 peer-reviewed papers and the securing of more than 60 antibody-related patents, cementing his status as a thought leader and innovator in the field.
As a talented educator and leader, Aaron places a strong emphasis on mentoring, continuous professional development, and fostering employee engagement, evident through his successful track record of building and leading high-performing teams comprising over 50 members, while nurturing valuable partnerships with industry stakeholders.
Aaron's academic journey includes pursuing a Doctor of Philosophy (PhD) in Biological Chemistry from the prestigious Massachusetts Institute of Technology, coupled with a Bachelor of Science (BS) in Chemistry from the University of Puget Sound, reflecting his strong foundation in scientific education and research.
His vast professional experience spans key roles in renowned organizations such as Twist Bioscience, LakePharma, Surrozen, Sutro Biopharma, OncoMed Pharmaceuticals, and Dyax, where he held executive positions focusing on biopharma, protein engineering, and antibody discovery, further consolidating his expertise and influence in the biotechnology sector.
